TY  - CHAP
M1  - Book, Section
TI  - Chronic Viral Hepatitis
A1  - Friedman, Lawrence S.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
PY  - 2021
T2  - Current Medical Diagnosis & Treatment 2021
AB  - Key  Clinical  Updates  in  Chronic  Viral  HepatitisIn  2019,  the  American  Association  for  the  Study  of  Liver  Diseases  and  the  Infectious  Diseases  Society  of  America  recommended  two  preferred  regimens  for  hepatitis  C:  glecaprevir  and  pibrentasvir  for  8  weeks  for  genotypes  1-6,  and  sofosbuvir  and  velpatasvir  for  12  weeks  for  genotypes  1,  2,  4,  5,  or  6.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2023/03/21
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1175808488
ER  -